Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GYRE THERAPEUTICS, INC. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 341K | Aug 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GYRE | GYRE THERAPEUTICS, INC. | Aug 14, 2024 | 1 | $0 | 4 | Aug 16, 2024 | Chief Executive Officer, Director |
CBIO | GYRE THERAPEUTICS, INC. | Oct 31, 2023 | 1 | $0 | 4 | Nov 1, 2023 | Director |
CBIO | GYRE THERAPEUTICS, INC. | Oct 30, 2023 | 0 | $0 | 3 | Nov 1, 2023 | Director |